Healius (ASX:HLS) share price higher on acquisition and rebrand news

This healthcare company’s shares have started the week strongly…
The post Healius (ASX:HLS) share price higher on acquisition and rebrand news appeared first on The Motley Fool Australia. –

The Healius Ltd (ASX: HLS) share price is on the move on Monday morning.

In early trade, the leading healthcare company’s shares are up 1% to $4.69.

This leaves the Healius share price trading within a whisker of a multi-year high.

Why is the Healius share price rising?

Investors have been bidding the Healius share price higher on Monday after it announced a new acquisition and rebranding.

According to the release, Healius has acquired Axis Diagnostic for an undisclosed fee. Management notes that Axis is a high-quality Queensland-based imaging business with operating earnings (EBITDA) of approximately $2 million.

It comprises three radiology practices located in growth areas near Brisbane and one practice in the Whitsundays.

Healius’ Managing Director & CEO, Dr Malcolm Parmenter, commented: “The acquisition is in line with our business’ network optimisation strategy, has been funded from cash and is EPS accretive. It complements and extends our existing footprint, grows revenue and capabilities, and delivers synergies with our facilities and national contracts.”


In addition to the acquisition, Healius has announced that its diagnostic imaging division, Healthcare Imaging Services and all its sub-brands, will be rebranding as Lumus Imaging. This will unify its imaging businesses under one national brand.

The release explains that the rebrand, with a new logo and colour scheme aligned to Healius, will see a stronger customer focus, improvements to the business’ online presence, and delivery of a more modern service.

Dr Malcolm Parmenter said: “Rebranding to Lumus Imaging supports Healius’ aim to be a customer centric healthcare business. In addition to refreshing our brand identity, we are updating our services, focusing on our digital capabilities and enhancing the way our business interacts with its patients and referrers.”

The rebrand will begin with seven sites across NSW and the ACT transitioning to Lumus Imaging in August. After which, the remaining sites across the country are expected to be completed over the next 18 months.

The Healius share price is up 24% in 2021.

The post Healius (ASX:HLS) share price higher on acquisition and rebrand news appeared first on The Motley Fool Australia.

Should you invest $1,000 in Healius right now?

Before you consider Healius, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Healius wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

More reading

The 5 best ASX 200 healthcare shares of financial year 2021

The Healius (ASX:HLS) share price hit a new 5-year high today
How these top ASX biotech shares performed in FY21

2 ASX healthcare shares analysts rate highly

2 ASX shares hitting record highs this week

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!